Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Amgen Terminates Co-Development of Brodalumab with AstraZeneca
This move follows the release of clinical trial data which suggests the experimental drug has severe side effects.
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Progress in AIDS Vaccine Research
Researchers have developed new vaccine candidates that are said to be promising enough to consider advancing into clinical trials within the next two years.
Two Treatments Yield Similar Results for Children After Cardiac Arrest
NIH-funded research finds therapeutic hypothermia no more effective than normal temperature control.
NIH-funded Study Points Way Forward for Retinal Disease Gene Therapy
Benefits for Leber congenital amaurosis peak after one to three years, then diminish.
Alcoholic Hepatitis Treatments Fail to Keep Patients Alive
The study is published in the New England Journal of Medicine.
NIH Launches Largest Clinical Trial Focused on HIV-related Cardiovascular Disease
Clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events.
No Evidence to Change Current Transfusion Practices for Adults
Study found no difference in the primary clinical measure between complex cardiac surgery patients.
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
Scroll Up
Scroll Down

High-Throughput Approaches to Cell Biology
Robin Ketteler, University College London, speaking at Screening Europe 2015.

Balancing Leverage with Stewardship of a Corporate Compound Collection
Rose Gonzales, Pfizer Global R&D, speaking at Drug Discovery and Development 2014

Pivot Park Screening Centre, The Pivot for Screening Knowledge and Expertise
Helma Rutjes, Pivot Park Screening Centre, speaking at Drug Discovery and Development 2014

Enabling New Pharma: Drug Re-purposing Efforts Go Mainstream. Innovative Alternatives for Stalled Pharmaceutical Pipelines
Rathnam Chaguturu, SRI International, speaking at Drug Discovery and Development 2014

Science for Life Laboratory Drug Discovery & Development Platform
Per Arvidson, Karolinska Institute, speaking at Drug Discovery and Development 2014

Characterizing the Early Drug Development Outsourcing Landscape
Stella Stergiopoulos, Tufts Center for the Study of Drug Design, speaking at Drug Discovery and Development 2014

ETP Nanomedicine and NANOMED2020: Towards a New Nanomedicine Horizon
Olivier Fontaine, Nanobiotix, speaking at Nanomedicine 2014.

Challenges of Implementing and Validating CTC Assays in Oncology Clinical Trials
Iman Jilani, Pfizer, speaking at Exosomes and Circulating Biomarkers Summit 2013.

Biomarker Development to Improve Trials for Type 1 Diabetes
Professor Matthias von Herrath, The La Jolla Institute for Allergy and Immunology, speaking at Exosomes and Circulating Biomarkers Summit 2013.

Companion Diagnostics Development at the Siemens Clinical Laboratory
Sunil Pandit, Siemens Healthcare Diagnostics, speaking at Exosomes and Circulating Biomarkers 2013.

<< 1 2 3 >>
Showing Results 1 - 10 of 29
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters